Product · #19 of 27 · multi-symptom

Kindra MenoRelief

Capsule from Kindra, made by Kindra. Daily serving: 1 capsule.

Last updated · Price and ratings checked Nov 19, 2026

In short: Kindra MenoRelief scores 48.1/100 in our ranking (#19 of 27). It costs $1.30 a day at the regular price. Evidence: Pycnogenol 100 mg + maca; best ingredient grade C (Pycnogenol (pine bark)). No NSF registry listing was confirmed.

Pros

  • None stood out.

Cons

  • No NSF registry listing confirmed (the brand says it is third-party tested).

Flags

None found

Score breakdown

Evidence
21/40
NSF-verified testing
8/20
Value ($/day)
11.1/20
Ingredients
4/10
Amazon rating
4/10

How we score

Full label: what's in it

Supplement Facts actives per daily serving (1 capsule). Source: label or official page, checked Nov 19, 2026.
Ingredient (as labeled)Per dayEvidence page
Pycnogenol French maritime pine bark extract100 mgPycnogenol (pine bark) C
Maca root powder500 mgMaca C-

Kindra also sells Core ($47; Pycnogenol + ashwagandha), which is not included here.

Evidence

Our evidence score: 21/40, because: Pycnogenol 100 mg + maca.

Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.

Ingredient evidence

  • Pycnogenol (pine bark) C (100 mg here)
    Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*. The Menopause Society 2023: Not assessed.
  • Maca C- (500 mg here)
    Maca is an Andean root food studied in a few small trials for mood and libido during menopause*. The trials were too few and too small to be conclusive. The Menopause Society 2023: Not recommended (Level II).

Studies

Studies on its ingredients (4)
  • Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial.

    Kohama T, Negami M · J Reprod Med 2013 · Pycnogenol (pine bark)

    170 Japanese women took a low dose of French maritime pine bark extract (60 mg a day) or placebo for 12 weeks. Symptoms, especially hot flashes and sleep, improved more than placebo, though placebo also helped a lot.

    Who
    170 perimenopausal women (Japan)
    Dose
    Pycnogenol 30 mg twice daily
    Duration
    12 weeks
    Result
    Kupperman -56% vs -39% placebo (P<.05); hot flashes and sleep improved.
    Funding
    Not stated in abstract (Horphag Research, maker, typically supports Pycnogenol trials; not verified). Funding not stated

    PubMed

  • A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.

    Yang HM, Liao MF, Zhu SY et al. · Acta Obstet Gynecol Scand 2007 · Pycnogenol (pine bark)

    About 200 Taiwanese women took 200 mg pine bark extract or placebo for 6 months, and symptoms improved more with the extract.

    Who
    200 enrolled, 155 completed (Taiwan)
    Dose
    Pycnogenol 200 mg/day
    Duration
    6 months
    Result
    All climacteric symptoms improved vs placebo; antioxidant status improved.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

  • Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review.

    Lee MS, Shin BC, Yang EJ et al. · Maturitas 2011 · Maca

    A review found only 4 small trials of maca for menopause; all were positive but too weak to be convincing.

    Who
    4 RCTs
    Dose
    maca, various
    Duration
    various
    Result
    All 4 showed favorable effects, but trials were few, small and of limited quality.
    Funding
    Academic (Korea/UK). Independent / academic

    PubMed · Full text (DOI)

  • Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.

    Brooks NA, Wilcox G, Walker KZ et al. · Menopause 2008 · Maca

    14 women took maca powder (3.5 g a day) and placebo for 6 weeks each. Mood and sexual-function scores improved on maca without changing hormones. Very small.

    Who
    14 postmenopausal women (crossover)
    Dose
    maca 3.5 g/day
    Duration
    6 weeks each arm
    Result
    Lower anxiety, depression and sexual-dysfunction scores vs placebo; no hormone changes.
    Funding
    Not stated in abstract. Funding not stated

    PubMed · Full text (DOI)

The Menopause Society's 2023 statement is in the study library.

Price

Regular one-time price$39.00 (30 units, 30 days at label dose)
Cost per day$1.30
Subscriptionnot shown
Price notes90 caps $99 (compare-at $117)
In stock when checkedYes
CheckedNov 19, 2026

Ratings

Amazon: No Amazon rating

Brand site: no average shown, 389 reviews on ourkindra.com (checked Nov 19, 2026). Brand-site reviews are moderated by the brand.

Star ratings reflect buyer satisfaction, not clinical effect.

Certifications and claims

Verified in a public registry

  • No registry listing found.

Claims made by the brand

  • “3rd-party tested (every batch: microbes, heavy metals, purity, potency)” Brand claim
  • “cGMP-certified, FDA-registered facilities” Brand claim
  • “vegan” Brand claim
  • “gluten-free” Brand claim
  • “non-GMO” Brand claim
  • “estrogen-free” Brand claim

Registry check: NSF/ANSI 173 ('Kindra'): not found

Who's behind it

BrandKindra
Owner / companyKindra (ourkindra.com), US femtech brand.
FoundersNot stated on the pages we read.
Where it's madeMade in the USA (brand claim). Brand claim
Medical advisors named
  • none named; 'recommended by 7,500+ healthcare providers'
Sourceourkindra.com

Flags & safety

Legal, regulatory and quality flags

  • Not sold on Amazon (2026-11-19).

Ingredient safety notes

Not verified

  • “3rd-party tested” claim (no public registry listing found). Unverified

Sources

Talk to a clinician first

The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).

If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.